Small-cap vaccine manufacturers have been some of the most volatile stocks on the market. As demand for a COVID-19 vaccine continues to grow, many companies working on potential treatments have seen their shares double or triple since the start of 2020.
Spirit AeroSystems (NYSE: SPR) has halted work on Boeing (NYSE: BA) commercial aircraft fuselages and furloughed more than 3,000 workers for 21 days following Boeing's decision to suspend final assembly due to the COVID-19 coronavirus pandemic.
Believe it or not, there will come a time when the coronavirus contagion is in the rearview mirror. For a few people, life will have changed dramatically. For most people, life will have changed at least a little. Whether it be due to a job loss, concern about the cleanliness of
Cannabis sales were soaring in March, especially during the first half of the month as the coronavirus became a global pandemic. Washington state saw a 9% increase in March's revenue from cannabis compared to the prior year, California's sales were up 53% year over year (althoug
When a company develops products that should be game changers in the way cancer is treated, it's going to generate a lot of buzz. That's exactly what has happened for Guardant Health (NASDAQ: GH).
In most years, April isn't a special month to buy stocks. It's not a bad time to invest, but there's nothing that makes April better than other months. But this April is different.
In most years, April isn't a special month to buy stocks. It's not a bad time to invest, but there's nothing that makes April better than other months. But this April is different.
Inovio Pharmaceuticals (NASDAQ: INO) has been making a lot of headlines lately. Thanks to its efforts to develop a vaccine for COVID-19, the company's stock is up by 150% year to date.
Marijuana users in Oregon bought $84.5 million worth of licensed product in March, according to data compiled by the state's Liquor Control Commission and cited in various media. That tally was 6.4% higher than in the previous month, and 30% above the March 2019 result. March 20
BioCryst Pharmaceuticals (NASDAQ: BCRX) has started a clinical trial to test its antiviral medication galidesivir in patients with COVID-19. The U.S. government's National Institute of Allergy and Infectious Diseases, which is part of the National Institutes of Health, is fundin
The following are today's upgrades for Validea's Contrarian Investor model based on the published strategy of David Dreman. This contrarian strategy finds the most unpopular mid- and large-cap stocks in the market and looks for improving fundamentals.
The following are today's upgrades for Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields.
The following are today's upgrades for Validea's Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth that trade at a discount relative to their earnings growth and dividend yield.
The following are today's upgrades for Validea's Book/Market Investor model based on the published strategy of Joseph Piotroski. This value-quant strategy screens for high book-to-market stocks, and then separates out financially sound firms by looking at a host of improving f
The following are today's upgrades for Validea's Price/Sales Investor model based on the published strategy of Kenneth Fisher. This value strategy rewards stocks with low P/S ratios, long-term profit growth, strong free cash flow and consistent profit margins.
In this episode of Industry Focus: Wildcard, Jason Moser and Motley Fool contributor Brian Feroldi give a breakdown of three great small caps you probably didn't know about. They range from a service provider to a surgical company and finally a research and consultancy firm. Fi
The coronavirus pandemic has millions of us holed up at home with little physical contact to the outside world. Companies like Peloton Interactive Inc. (NASDAQ: PTON), which manufactures home fitness equipment and produces video workout classes, would seem poised to take advant
The Motley Fool
Checked
19 minutes 26 seconds ago
This feed is responsible for generating the rss feed related to the topic Markets